AKRO - Akero Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AKRO is currently covered by 5 analysts with an average price target of $82.24. This is a potential upside of $28.16 (52.07%) from yesterday's end of day stock price of $54.08.

Akero Therapeutics's activity chart (see below) currently has 102 price targets and 76 ratings on display. The stock rating distribution of AKRO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.06% with an average time for these price targets to be met of 323 days.

Highest price target for AKRO is $109, Lowest price target is $73, average price target is $83.2.

Most recent stock forecast was given by MICHAEL ULZ from MORGAN STANLEY on 11-May-2025. First documented stock forecast 14-Jul-2019.

Currently out of the existing stock ratings of AKRO, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$84

$37.9 (82.21%)

$90

4 months 28 days ago
(11-May-2025)

3/8 (37.5%)

$42.47 (102.26%)

350

Buy

$75

$28.9 (62.69%)

$72

7 months 7 days ago
(02-Mar-2025)

12/25 (48%)

$29.46 (64.69%)

265

Buy

$109

$62.9 (136.44%)

$42

8 months 9 days ago
(30-Jan-2025)

2/4 (50%)

$54.92 (101.55%)

401

Buy

$75

$28.9 (62.69%)

$48

8 months 11 days ago
(28-Jan-2025)

2/3 (66.67%)

$21 (38.89%)

464

Buy

$73

$26.9 (58.35%)

$56

8 months 12 days ago
(27-Jan-2025)

5/8 (62.5%)

$21.53 (41.83%)

450

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AKRO (Akero Therapeutics) average time for price targets to be met?

On average it took 323 days on average for the stock forecasts to be realized with a an average price target met ratio 54.06

Which analyst has the current highest performing score on AKRO (Akero Therapeutics) with a proven track record?

EDWARD NASH

Which analyst has the most public recommendations on AKRO (Akero Therapeutics)?

Edward Nash works at CANACCORD and has 5 price targets and 6 ratings on AKRO

Which analyst is the currently most bullish on AKRO (Akero Therapeutics)?

Eliana Merle with highest potential upside - $62.9

Which analyst is the currently most reserved on AKRO (Akero Therapeutics)?

Liisa Bayko with lowest potential downside - -$8.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?